Financials
- Financial year
- 2025
- Total assets
- €2.7m
- Profit
- €274,841
- Solvency
- 13.1%
Total assets▲ 61.0%
Net result
20242025
Apotheek Knesselare
ActiveSummary
Apotheek Knesselare has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €349,695 and a net result of €274,841. Its solvency ranks better than 24% of 12,686 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €1.9mturnover 2025, estimated
- Equity
- €349,695
- Profit
- €274,841
Turnover estimated from the gross margin
Why 85raises riskFounded in 2024Equity €349,695 (13.1% of total assets)lowers riskSize: total assets €2.7mFigures for financial year 2025 (filed 23-07-2026)Show the evidence
Checked score
Score 2025
85
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 63% of its sector peers (NACE 47, small)
Financial strength · tick = 2024
Average
Solvency
38+8
equity 13.1% of total assets
Liquidity
42+1
short-term debt 53.1% · cash 15.0%
Profitability
82+9
return on assets 10.3%
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
04-2025: 1.8%
05-2025: 1.9%▲ +0.1 percentage points vs 04-2025
06-2025: 1.9%● unchanged vs 05-2025
07-2025: 2.3%▲ +0.4 percentage points vs 06-2025
08-2025: 2.3%● unchanged vs 07-2025highest value
09-2025: 1.4%▼ -0.9 percentage points vs 08-2025
10-2025: 1.5%▲ +0.1 percentage points vs 09-2025
11-2025: 1.5%● unchanged vs 10-2025
12-2025: 1.5%● unchanged vs 11-2025
01-2026: 1.5%● unchanged vs 12-2025
02-2026: 1.5%● unchanged vs 01-2026
03-2026: 1.6%▲ +0.1 percentage points vs 02-2026
04-2026: 1.5%▼ -0.1 percentage points vs 03-2026
05-2026: 1.5%● unchanged vs 04-2026
06-2026: 1.7%▲ +0.2 percentage points vs 05-2026
07-2026: 1.9%▲ +0.2 percentage points vs 06-2026
08-2026: 0.4%▼ -1.5 percentage points vs 07-2026
09-2026: 0.4%● unchanged vs 08-2026
10-2026: 0.4%● unchanged vs 09-2026lowest value
Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity insufficient (current ratio 0.64, compared with 0.94 in 2024, below 1; short-term debt: 53.1% and cash: 15% of total assets), and 86.9% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 26% on solvency, 48% on liquidity, 81% on profitability and 98% on growth.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 12686 sector peers (2025).
NBB · sector comparisonPosition among 12686 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
8 days early
2024
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 2 accounts on average 10 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
28-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Equity above €200,000equity €349,695 ▲367%
- Annual accounts filedfinancial year 2024 · abbreviated…
Key points
By topic
Board & ownership
- Board
- 1 member
- COVEMAEKER Tom Georges MimiDirector
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 4
- Since
- 2024
- Next accounts
- by 31-07-2027
- 11-03-2024Incorporation
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 07-03-2024
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 23
- Annual meeting
- Fourth Saturday of June at 20:00
- Purpose
- “Het oprichten,overnemen en uitbaten van een apotheek of apotheken met alle hieronder…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Key facts about Apotheek Knesselare
- What is the company number of Apotheek Knesselare?
- 1006.890.781. In Belgium the VAT number is the company number with BE in front: BE 1006.890.781.
- Where is Apotheek Knesselare based?
- The registered office is at Kerkstraat 29, 9910 Aalter.Company details
- What does Apotheek Knesselare do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Apotheek Knesselare?
- Private limited company (BV).
- When was Apotheek Knesselare founded?
- On 07-03-2024.
- Is Apotheek Knesselare still active?
- Yes, Apotheek Knesselare is an active enterprise in the KBO register.
- How many employees does Apotheek Knesselare have?
- On average 1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- What is the turnover of Apotheek Knesselare?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is Apotheek Knesselare profitable?
- In financial year 2025, Apotheek Knesselare made a profit of €274,841.
- Where can I find the annual accounts of Apotheek Knesselare?
- Apotheek Knesselare filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Apotheek Knesselare due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Apotheek Knesselare
Subsidiaries and holdings
Comparable companies
- VRB FARMAMechelen
- Apotheek Op de Beeck-NeefsRumst
- PHARMACIE BRONFORTLiège
- Apoteek SINT ROCHUSHalle
- WpauwelsBornem
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.